Potassium (KV) Channels – SGLT2 Inhibitor Combination Therapy in Chronic Limb-threatening Ischemia Patients

The bound ligand concentration was then determined by the difference of the total antibody mass added to the particles minus the free ligand mass, normalized by the mass of particles

The bound ligand concentration was then determined by the difference of the total antibody mass added to the particles minus…

Here, we have described a novel LDLR-CD81 interaction that may contribute to HCV entry

Here, we have described a novel LDLR-CD81 interaction that may contribute to HCV entry. or hinge-cysteine-histidine-rich domain domains of PCSK9…

Type to search